GB202011140D0 - Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury - Google Patents

Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Info

Publication number
GB202011140D0
GB202011140D0 GBGB2011140.7A GB202011140A GB202011140D0 GB 202011140 D0 GB202011140 D0 GB 202011140D0 GB 202011140 A GB202011140 A GB 202011140A GB 202011140 D0 GB202011140 D0 GB 202011140D0
Authority
GB
United Kingdom
Prior art keywords
cannabidiol
treatment
brain injury
seizures associated
syndromes related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2011140.7A
Other versions
GB2597296A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Research Ltd
Original Assignee
GW Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Research Ltd filed Critical GW Research Ltd
Priority to GB2011140.7A priority Critical patent/GB2597296A/en
Publication of GB202011140D0 publication Critical patent/GB202011140D0/en
Priority to PCT/EP2021/069886 priority patent/WO2022017950A1/en
Publication of GB2597296A publication Critical patent/GB2597296A/en
Pending legal-status Critical Current

Links

GB2011140.7A 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury Pending GB2597296A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2011140.7A GB2597296A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
PCT/EP2021/069886 WO2022017950A1 (en) 2020-07-20 2021-07-15 Use of cannabidiol in the treatment of seizures associated with bilateral mesial temporal sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2011140.7A GB2597296A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Publications (2)

Publication Number Publication Date
GB202011140D0 true GB202011140D0 (en) 2020-09-02
GB2597296A GB2597296A (en) 2022-01-26

Family

ID=72339101

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2011140.7A Pending GB2597296A (en) 2020-07-20 2020-07-20 Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury

Country Status (2)

Country Link
GB (1) GB2597296A (en)
WO (1) WO2022017950A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2487712B (en) * 2011-01-04 2015-10-28 Otsuka Pharma Co Ltd Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
GB201806953D0 (en) * 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations

Also Published As

Publication number Publication date
GB2597296A (en) 2022-01-26
WO2022017950A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
GB202011150D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011123D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011140D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury
GB202011161D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011175D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011143D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abbormalities of the brain
GB202110388D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011141D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011120D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011146D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011152D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011155D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011137D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011119D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011131D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011130D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain
GB202011128D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes
GB202019301D0 (en) Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes
GB202011125D0 (en) Use of cannabidiol in the treatment of seizures associated wiht rare epilepsy syndromes related to structural abnormalities of the brain
GB202011159D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011174D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011156D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011127D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011134D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
GB202011160D0 (en) Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities